According to research by SNS Insider, the U.S. Cell Analysis Market is projected to grow at a CAGR of 9.77%, Fueled by strong biotechnology capabilities, expanding precision medicine initiatives & ...

Invivoscribe Inc., a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to support CERo Therapeutics Holdings, Inc., an innovative immunotherapy company ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial Invivoscribe Inc., a ...

SAN DIEGO--(BUSINESS WIRE)--#invivoscribe--Invivoscribe Inc., a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to support CERo Therapeutics Holdings, ...

NEW YORK – Precision diagnostics company Invivoscribe said Tuesday that it will support Cero Therapeutics' ongoing Phase I trial of CER-1236, an autologous T-cell therapy, in patients with acute ...

Please provide your email address to receive an email when new articles are posted on . Use of multiparametric MRI led to significantly higher diagnosis rates in all hospitals studied. Patients ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd. Over the past decade, measurable residual disease (MRD) has emerged as a critical tool for detecting and ...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and an Operating Company of Danaher Corporation, revolutionizes spectral flow cytometry with the industry’s ...